대장내시경 검사 기기 시장 : 제품 유형별, 최종사용자별, 용도별, 지역별(2026-2032년)

Colonoscopy Devices Market Valuation-2026-2032

The market for colonoscopy devices is quickly rising as colorectal cancer rates rise and the number of colonoscopy procedures conducted worldwide increases. Also, the market is expected to grow because of the high demand for innovative, technologically sophisticated gadgets and colonoscopy equipment. According to the analyst from Verified Market Research, the Colonoscopy Devices Market is estimated to reach a valuation of USD 2.25 Billion over the forecast period 2032, subjugating around USD 1.59 Billion valued in 2024.

The rising frequency of colorectal cancer, as well as the expanding acceptance of preventative screening programs, are driving the Colonoscopy Devices Market. It enables the market to grow at a CAGR of 5% from 2026-2032.

How is the Geriatric Population Driving the Colonoscopy Devices Market?

The increasing aging population globally, and the increasing prevalence of chronic disorders over the globe are driving the Colonoscopy Devices Market. According to the World Health Organization (WHO) in 2020 almost 1.4 billion people were above 60 years aged. The risk of colorectal cancer is increasing in adults, which is fueling the demand for colonoscopy devices. According to the National Cancer Institute, globally 36.6% of people per 100,000 men and women were detected by colorectal cancer. The death rate was 13.1% per 100,000 men and women per year.

The increasing number of colorectal cancer is predicted by the National Library of Medicine by 2040 will be 3.2 million and the disease is leading to more frequent colonoscopy procedures.

Furthermore, increasing knowledge about colorectal cancer educational programs and public health campaigns are doing a good job of bringing colorectal cancer and the value of colonoscopies as a preventive screening to light. As a result of this greater awareness, more people are choosing to have colonoscopies, which propels market expansion.

How Does Risk of Infection Constrain the Growth of the Colonoscopy Devices Market?

Despite advances in gadget design and sterilizing measures, there is still a danger of cross-contamination and infection transmission during colonoscopy procedures. According to the National Library of Medicine, colorectal cancer is the second cancer. Recent examinations show that more than 300,000 people were detected with colorectal cancer. The thorough cleaning and sanitation of reusable endoscopic equipment is vital, but it poses logistical and cost issues. Single-use devices have been offered as a solution to this problem, however, they significantly enhance the cost of treatments while also raising concerns about medical waste and the environment.

Furthermore, the high expense of both the gadgets and the procedures themselves is a significant impediment to the widespread use of colonoscopy. The development of sophisticated colonoscopy gadgets necessitates extensive R&D, regulatory compliance expenditures, and manufacturing complexity. These costs are passed on to healthcare providers and, eventually, patients. In nations with less comprehensive health insurance coverage or lesser economic growth, these expenses severely limit access to potentially life-saving surgeries.

Category-Wise Acumens

Will Visualization Systems Outplace Colonoscopy Device Market?

The visualization system is estimated to exhibit the highest growth within the market during the forecast period. The visualization system is used to screen for cancer in the small intestine, rectum, and anus. A minimally intrusive diagnostic for assessing the possibility of internal organ cancer is a virtual colonoscopy.

Screening (CT) colonography is another name for virtual colonoscopy. It is used for radiologist X-rays. It finds the diseases at an early stage. According to the National Institute of Diabetes and Digestive and Kidney Diseases, doctors recommend CT screening for colonoscopy and rectal cancer at the age of 45 if there is no health issue.

Furthermore, colonoscopy usage is expected to increase as long as technology continues to evolve, leading to better mobility and disposable choices. Visualization systems currently don't outplace colonoscopy devices.

How the increasing prevalence of Colorectal Cancer in adults is driving the Colorectal Cancer segment?

The colorectal cancer segment is estimated to dominate the market during the forecast period. In the U.S. around 18,000 people under the age of 50 are getting diagnosed with colorectal cancer. According to the National Cancer Institute, the risk of colorectal cancer is increasing in older adults because of smoking, physical inactivity, and obesity.

Risk fare increasing in adults under the age of 45, 10% to 20% of early-onset colorectal cancer is caused because of inherited factors. Due to an unhealthy diet, and low intake of fruits and vegetables the early stage the cancer is caused.

Furthermore, the growth incidence and its impact on the demand for colonoscopy devices can be attributed to several factors such as lifestyle, rising healthcare expenditure, increasing awareness, and screening efforts. The combination of demographic trends and infrastructure improvements contributes to the growing incidence of colorectal cancer and, consequently, the increasing demand for colonoscopy devices.

Country/Region-wise Acumens

How does the Developed Healthcare System Drive the North American Colonoscopy Devices Market?

North America region is estimated to dominate the market during the forecast period due to the improving prevalence of rectal diseases, the existence of a developed healthcare system, the growing emphasis on the development of innovative products, and the increasing number of companies manufacturing colonoscopy devices. The governments are running several health campaigns to raise awareness of colon problems among the local populace.

North America, particularly the United States, has one of the most advanced healthcare systems in the world. This comprises cutting-edge medical facilities, advanced medical technologies, and highly skilled healthcare staff. Also, healthcare spending in the region is far higher than in other parts of the world. This financial commitment promotes the use of modern medical technology, particularly colonoscopy machines, which aid in the early identification and treatment of gastrointestinal disorders such as colorectal cancer.

Furthermore, Colorectal cancer is common in North America and is the biggest cause of cancer-related fatalities in the region. The American Cancer Society emphasizes the significance of regular screening for early identification of colorectal cancer, which drives up demand for colonoscopy instruments. Also, the increasing prevalence of other gastrointestinal disorders as a result of food habits, lifestyle changes, and an older population drives up demand for these devices.

What Factors Contribute to the Growth of the Asia Pacific Region in the Market?

The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. Countries in the Asia Pacific region, including China, India, and Japan, are experiencing significant increases in healthcare spending, both at the government and individual levels. This increased spending is being directed toward modernizing healthcare infrastructure, such as hospitals and diagnostic facilities outfitted with cutting-edge medical technology. As healthcare accessibility grows, so does the adoption of advanced diagnostic instruments, such as colonoscopy devices, to meet an increasing demand for high-quality healthcare services.

Furthermore, the Asia Pacific region is experiencing a rapid increase in the prevalence of colorectal cancer and other gastrointestinal disorders, which can be ascribed to changing lifestyles, dietary habits, and aging populations. These factors have raised awareness about the need for early detection and prevention, increasing demand for colonoscopy treatments. Countries such as Japan have adopted screening programs that encourage regular colonoscopies, setting an example for other nations in the region.

Competitive Landscape

The competitive landscape of the colonoscopy device market is characterized by several key players and factors that influence market dynamics, innovation, and strategic initiatives. These players compete based on product offerings, technological advancements, market presence, pricing strategies, distribution networks, and partnerships.

Some of the prominent players operating in the Colonoscopy Devices Market include:

Boston Scientific, PENTAX Medical, Fujifilm Holdings, HOYA Group, Avantis Medical System, KARL STORZ, Medtronic, OLYMPUS, ANA-MED, Endomed Systems, Getinge Group, GI-View, HUGER Medical Instrument

Latest Developments

In March 2022, the FDA approved Wision A.I.'s colonoscopy technology for polyp detection. This approval will enhance patient outcomes and contribute to a decrease in colorectal cancer incidences.

In April 2022, Olympus 510(k) cleared the PCF colonoscope series, and SMART Medical Systems Ltd., a producer of cutting-edge endoscopic equipment, announced an additional Food and Drug Administration clearance for their G-EYE Colonoscope.

Colonoscopy Devices Market By Category

Product Type:

Visualization system

Colonoscope

Other instruments

End-use:

Hospitals

Clinics

Ambulatory Surgery Centers

Diagnostic Centers

Other

Application:

Colorectal Cancer

Lynch Syndrome

Ulcerative Colitis

Crohn's Disease

Polyps or Colorectal Cancer

Other Applications

Region:

North America

Europe

Asia-Pacific

South America

Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL COLONOSCOPY DEVICES MARKET

• 1.1. Overview of the Market
• 1.2. Scope of Report
• 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1. Data Mining
• 3.2. Validation
• 3.3. Primary Interviews
• 3.4. List of Data Sources

4. GLOBAL COLONOSCOPY DEVICES MARKET OUTLOOK

• 4.1. Overview
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
• 4.3. Porters Five Force Model
• 4.4. Value Chain Analysis

5. GLOBAL COLONOSCOPY DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Visualization system
• 5.3 Colonoscope
• 5.4 Other instruments

6. GLOBAL COLONOSCOPY DEVICES MARKET, BY END-USE

• 6.1. Overview
• 6.2 Hospitals
• 6.3 Clinics
• 6.4 Ambulatory Surgery Centers
• 6.5 Diagnostic Centers
• 6.6 Other

7. GLOBAL COLONOSCOPY DEVICES MARKET, BY APPLICATION

• 7.1. Overview
• 7.2 Colorectal Cancer
• 7.3 Lynch Syndrome
• 7.4 Ulcerative Colitis
• 7.5 Crohn's Disease
• 7.6 Polyps or Colorectal Cancer
• 7.7 Other Applications

8. GLOBAL COLONOSCOPY DEVICES MARKET, BY GEOGRAPHY

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. U.K.
  • 8.3.3. France
  • 8.3.4. Rest of Europe
• 8.4. Asia Pacific
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Rest of Asia Pacific
• 8.5. Rest of the World
  • 8.5.1. Latin America
  • 8.5.2. Middle East & Africa

9. GLOBAL COLONOSCOPY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1. Overview
• 9.2. Company Market Ranking
• 9.3. Key Development Strategies

10. COMPANY PROFILES

• 10.1. Boston Scientific
  • 10.1.1. Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Outlook
  • 10.1.4. Key Developments
• 10.2. Fujifilm Holdings
  • 10.2.1. Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Outlook
  • 10.2.4. Key Developments
• 10.3. HOYA Group
  • 10.3.1. Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Outlook
  • 10.3.4. Key Developments
• 10.4. KARL STORZ
  • 10.4.1. Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Outlook
  • 10.4.4. Key Developments
• 10.5. OLYMPUS
  • 10.5.1. Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Outlook
  • 10.5.4. Key Developments
• 10.6. ANA-MED
  • 10.6.1. Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Outlook
  • 10.6.4. Key Developments
• 10.7. Avantis Medical Systems
  • 10.7.1. Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Outlook
  • 10.7.4. Key Developments
• 10.8. Endomed Systems
  • 10.8.1. Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Outlook
  • 10.8.4. Key Developments
• 10.9. Getinge Group
  • 10.9.1. Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Outlook
  • 10.9.4. Key Developments
• 10.10. HUGER Medical Instrument
  • 10.10.1. Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Outlook
  • 10.10.4. Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12. Appendix

• 12.1. Related Research